Kurz KD - Search Results

1

Engineering the proteolytic specificity of activated protein C improves its pharmacological properties.

Berg DT, Gerlitz B, Shang J, Smith T, Santa P, Richardson MA, Kurz KD, Grinnell BW, Mace K, Jones BE. Berg DT, et al. Among authors: kurz kd. Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4423-8. doi: 10.1073/pnas.0736918100. Epub 2003 Apr 1. Proc Natl Acad Sci U S A. 2003. PMID: 12671072 Free PMC article.

2

Antithrombotic efficacy in the guinea pig of a derivative of human protein C with enhanced activation by thrombin.

Kurz KD, Smith T, Wilson A, Gerlitz B, Richardson MA, Grinnell BW. Kurz KD, et al. Blood. 1997 Jan 15;89(2):534-40. Blood. 1997. PMID: 9002956 Free article.

3

Structure-based design of potent, amidine-derived inhibitors of factor Xa: evaluation of selectivity, anticoagulant activity, and antithrombotic activity.

Wiley MR, Weir LC, Briggs S, Bryan NA, Buben J, Campbell C, Chirgadze NY, Conrad RC, Craft TJ, Ficorilli JV, Franciskovich JB, Froelich LL, Gifford-Moore DS, Goodson T Jr, Herron DK, Klimkowski VJ, Kurz KD, Kyle JA, Masters JJ, Ratz AM, Milot G, Shuman RT, Smith T, Smith GF, Tebbe AL, Tinsley JM. Wiley MR, et al. Among authors: kurz kd. J Med Chem. 2000 Mar 9;43(5):883-99. doi: 10.1021/jm9903287. J Med Chem. 2000. PMID: 10715155

4

Non-amidine-containing 1,2-dibenzamidobenzene inhibitors of human factor Xa with potent anticoagulant and antithrombotic activity.

Masters JJ, Franciskovich JB, Tinsley JM, Campbell C, Campbell JB, Craft TJ, Froelich LL, Gifford-Moore DS, Hay LA, Herron DK, Klimkowski VJ, Kurz KD, Metz JT, Ratz AM, Shuman RT, Smith GF, Smith T, Towner RD, Wiley MR, Wilson A, Yee YK. Masters JJ, et al. Among authors: kurz kd. J Med Chem. 2000 Jun 1;43(11):2087-92. doi: 10.1021/jm990625b. J Med Chem. 2000. PMID: 10841787 No abstract available.

5

Comparative QSAR studies of two series of 1,4-dihydropyridines as slow calcium channel blockers.

Wikel JH, Bemis KG, Kurz K, Denney ML, Main BW, Moore RA, Smith T, Shingleton L, Holland DR. Wikel JH, et al. Drug Des Discov. 1994 Jan;11(1):1-14. Drug Des Discov. 1994. PMID: 8068815

6

A family of arginal thrombin inhibitors related to efegatran.

Smith GF, Shuman RT, Craft TJ, Gifford DS, Kurz KD, Jones ND, Chirgadze N, Hermann RB, Coffman WJ, Sandusky GE, Roberts E, Jackson CV. Smith GF, et al. Among authors: kurz kd. Semin Thromb Hemost. 1996;22(2):173-83. doi: 10.1055/s-2007-999006. Semin Thromb Hemost. 1996. PMID: 8807715

7

Comparative 5-HT2-receptor antagonist activity of amesergide and its active metabolite 4-hydroxyamesergide in rats and rabbits.

Cohen ML, Kurz KD, Fuller RW, Calligaro DO. Cohen ML, et al. Among authors: kurz kd. J Pharm Pharmacol. 1994 Mar;46(3):226-9. doi: 10.1111/j.2042-7158.1994.tb03784.x. J Pharm Pharmacol. 1994. PMID: 8027933

8

Rat model of arterial thrombosis induced by ferric chloride.

Kurz KD, Main BW, Sandusky GE. Kurz KD, et al. Thromb Res. 1990 Nov 15;60(4):269-80. doi: 10.1016/0049-3848(90)90106-m. Thromb Res. 1990. PMID: 2087688

9

Pinacidil-induced vascular relaxation: comparison to other vasodilators and to classical mechanisms of vasodilation.

Cohen ML, Kurz KD. Cohen ML, et al. Among authors: kurz kd. J Cardiovasc Pharmacol. 1988;12 Suppl 2:S5-9. J Cardiovasc Pharmacol. 1988. PMID: 2466179

10

Preclinical studies on LY237733, a potent and selective serotonergic antagonist.

Foreman MM, Fuller RW, Nelson DL, Calligaro DO, Kurz KD, Misner JW, Garbrecht WL, Parli CJ. Foreman MM, et al. Among authors: kurz kd. J Pharmacol Exp Ther. 1992 Jan;260(1):51-7. J Pharmacol Exp Ther. 1992. PMID: 1731051

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

73 results

Search Page